According to Straits Research, the global pet cancer therapeutics market size was valued at USD 395.74 Million in 2022.
It is projected to reach from USD XX Million in 2023 to USD 837.75 Million by 2031, growing at a CAGR of 8.69% during the forecast period (2023–2031).